Current Drug Therapy
Title:Meet the Editorial Board Member
Volume: 16 Issue: 2
Author(s): Bechan Sharma
Affiliation:
Export Options
About this article
Cite this article as:
Sharma Bechan , Meet the Editorial Board Member, Current Drug Therapy 2021; 16 (2) . https://dx.doi.org/10.2174/157488551602210604092815
DOI https://dx.doi.org/10.2174/157488551602210604092815 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
15
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Frontotemporal Lobar Degeneration (FTLD): Review and Update for Clinical Neurologists
Current Alzheimer Research The 21st Century Form of Vitamin E - Tocotrienol
Current Pharmaceutical Design Profiling the Structural Determinants of Heteroarylnitrile Scaffold-Based Derivatives as Falcipain-2 Inhibitors by In Silico Methods
Current Medicinal Chemistry Levocetirizine: An Update
Current Medicinal Chemistry Recent Trends in Glycodendrimer Syntheses and Applications
Current Topics in Medicinal Chemistry Antiangiogenesis Potential of Alpinumisoflavone as an Inhibitor of Matrix Metalloproteinase-9 (MMP-9) and Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2)
Current Enzyme Inhibition G Protein-Coupled Receptors: Target-Based In Silico Screening
Current Pharmaceutical Design Translational Imaging of Apoptosis
Anti-Cancer Agents in Medicinal Chemistry Identification of Ligand-Binding Pockets in Proteins Using Residue Preference Methods
Protein & Peptide Letters An Overview of Bioactive Peptides for in vivo Imaging and Therapy in Human Diseases
Mini-Reviews in Medicinal Chemistry DESIGN, <i>In silico</i> Modeling, Toxicity study and Synthesis of Novel Substituted Semicarbazide Derivatives of Pyrimidine: An Antitubercular Agent
Current Bioactive Compounds Mast Cell Tryptase β as a Target in Allergic Inflammation: An Evolving Story
Current Pharmaceutical Design Improved Pharmacokinetic Profile and Anti-Inflammatory Property of a Novel Curcumin Derivative, A50
Letters in Drug Design & Discovery Considering Environmental Health and Energy Resources to Design Transformers
Current Signal Transduction Therapy Amantadine Might be Used as a Drug for SARS-Cov-2 Treatment?
Coronaviruses Factors Influencing Outcome of Patients Receiving Extracorporeal Membrane Oxygenation for Neonatal and Pediatric Respiratory Failure
Current Respiratory Medicine Reviews Enzyme Inhibitors
Current Bioactive Compounds Biological Carrier Molecules of Radiopharmaceuticals for Molecular Cancer Imaging and Targeted Cancer Therapy
Current Pharmaceutical Design Natural Products, a Potential Therapeutic Modality in Management and Treatment of nCoV-19 Infection: Preclinical and Clinical Based Evidence
Current Pharmaceutical Design Molecular Docking, DFT Studies and ADMET Simulations for Evaluating Already Approved FDA Drugs as Inhibitors for SARS-Cov-2 RNADependent Polymerase
Letters in Drug Design & Discovery